Skeletal and extra-skeletal consequences of vitamin D defi ciency;A D-vitamin-hiány csontrendszeri és csontrendszeren kívüli következményei

Orvosi Hetilap

Volumn 152, Issue 33, 2011, Pages 1312-1319

  Szabó, András ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

active vitamin D; plain vitamin D; vitamin D defi ciency

Indexed keywords

25 HYDROXYVITAMIN D;

ARTICLE; BONE DISEASE; DISEASE EXACERBATION; GROWTH RETARDATION; HIP FRACTURE; HUMAN; MORBIDITY; MUSCLE WEAKNESS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; SKELETON MALFORMATION; VITAMIN D DEFICIENCY;

EID: 80051754906     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2011.29186     Document Type: Article

References (35)

1. Holick, M. F.: Evolution and function of vitamin D. Recent Results. Cancer Res., 2003, 164, 3-28.
2. Whistler, D.: Morbo puerili Anglorum, quem patrio idiomate indigenae vocant The Rickets. Lugduni Batavorum, 1645, 1-13.
3. Glisson, F.: De Rachitide sive morbo puerili, qui vulgo The Rickets dicitur. London, 1650, 1-416.
4. Skrobacki, A., Kikta, T.: Jedrzej Sniadecki (1768-1838), Polish physician and chemist. Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete, 1980, 26, 67-69.
5. Mellanby, E., Cantag, M. D.: Experimental investigation on rickets. Lancet, 1919, 196, 407-412.
6. Norman, A. V.: Vitamin D: The calcium homeostasis steroid hormon. Academic Press, New York, 1979.
7. Tangpricha, V., Pearce, E. N., Holick, M. F. és mtsai: Vitamin D insuffi ciency among free-living healthy young adults. Am. J. Med., 2002, 112, 659-662. (Pubitemid 34597167)
8. Yetley, E. A., Pfeiffer, C. M., Schleicher, D. és mtsai: Vitamin D roundtable on the NHANES monitoring of serum 25(OH)D: Assay challenges and options for resolving them. NHANES monitoring of serum 25-hydroxyvitamin D: A roundtable summary. J. Nutr., 2010, 140, 2030S-2045S.
9. Freedman, D. M., Looker, A. C., Abnet, C. C. és mtsai: Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res., 2010, 70, 8587-8597.
10. Zhao, G., Ford, E. S., Li, C.: Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among U. S. adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care, 2010, 33, 344-347.
11. Kumar, J., Muntner, P., Kaskel, F. J. és mtsai: Prevalence and associations of 25-hydroxyvitamin D defi ciency in US children: NHANES 2001-2004. Pediatrics, 2009, 124, 362-370.
12. Mehrotra, R., Kermah, D. A., Salusky, I. B. és mtsai: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int., 2009, 76, 977-983.
13. Costello, R. B.: Vitamin D and health in the 21st century: federal initiatives to advance research. Am. J. Med. Sci., 2009, 338, 34-39.
14. Kendrick, J., Targher, G., Smits, G. és mtsai: 25-hydroxyvitamin D defi ciency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis, 2009, 205, 255-260.
15. Looker, A. C., Pfeiffer, C. M., Lacher, D. A. és mtsai: Serum 25-hydroxyvitamin D status of the US population: 1988-1994 com- pared with 2000-2004. Am. J. Clin. Nutr., 2008, 88, 1519-1527.
16. Ginde, A. A., Liu, M. C., Camargo, C. A. Jr.: Demographic differences and trends of vitamin D insuffi ciency in the US population, 1988-2004. Arch. Intern. Med., 2009, 169, 626-632.
17. Adams, J. S., Hewison, M.: Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab., 2008, 4, 80-90. (Pubitemid 351156900)
18. Björn, L. O., Wang, T.: Vitamin D in an ecological context. Int. J. Circumpolar Health, 2000, 59, 26-32.
19. Stumpf, W. E., Sar, M., Reid, F. A. és mtsai: Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science, 1979, 206, 1188-1190. (Pubitemid 10159658)
20. Norman, A. W.: Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology, 2006, 147, 5542-5548. (Pubitemid 44833469)
21. Szabó, A., Merke, J., Ritz, E. és mtsai: 1,25(OH)2-vitamin-D3 inhibits parathyroid proliferation in experimental uremia. Kidney Int., 1989, 35, 1049-1056. (Pubitemid 19099719)
22. Green, D. M., Leonard, A. R., Paranjape, S. M. és mtsai: Transient effectiveness of vitamin D2 therapy in pediatric cystic fi brosis patients. J. Cyst. Fibros., 2010, 9, 143-149.
23. Wang, T. J., Zhang, F., Richards, J. B. és mtsai: Common genetic determinants of vitamin D insuffi ciency: A genom-wide association study. Lancet, 2010, 376, 180-188.
24. Bosomworth, N. J.: Mitigating epidemic of vitamin D defi ciency: The agony of evidence. Can. Fam. Physician, 2011, 57, 16-20.
25. Heaney, R. P.: Functional indices of vitamin D status and ramifi - cations of vitamin D defi ciency. Am. J. Clin. Nutr., 2004, 80 (Suppl.), 1706S-1709S.
26. Pepper, K. J., Judd, S. E., Nanes, M. S. és mtsa: Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr. Pract., 2009, 15, 95-103.
27. Barger, M. K.: Maternal nutrition and perinatal outcomes. J. Midwifery Womens Health, 2010, 55, 502-511.
28. Barett, H.: Vitamin D and pregnancy: An old problem revisited. Best Pract. Res. Clin. Endocrinol. Metab., 2010, 24, 527-539.
29. Rosen, C. J.: Clinical practice. Vitamin D insuffi ciency. N. Engl. J. Med., 2011, 364, 248-254.
30. Bolland, M. J., Avenell, A., Baron, J. A. és mtsai: Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. Br. Med. J., 2010, 341, c3691.
31. Dobnig, H., Pilz, S., Scharnagl, H. és mtsai: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med., 2008, 168, 1340-1349. (Pubitemid 351930842)
32. Autier, P., Gandini, S.: Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch. Intern. Med., 2007, 167, 1730-1737. (Pubitemid 47403059)
33. Ridker, P. M., Danielson, E., Fonseca, F. A. és mtsai, for the JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med., 2008, 359, 2195-2207.
34. Freedman, D. M., Looker, A. C., Chang, S. C. és mtsai: Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl. Cancer Inst., 2007, 99, 1594-1602.
35. Kauffmann, J. M.: Benefi ts of vitamin D supplementation. J. Am. Phys. Surg., 2009, 14, 38-45.